MedTrace Logo

Influence of Creatine Monohydrate Supplementation on Androgens and Global Hair Assessments

NCT04298840 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-09-14

No results posted yet for this study

Summary

This study is a randomized, double-blind, placebo-controlled trial examining the effects of creatine monohydrate supplementation on androgens and hair loss in free-living adult males. Participants will complete 6 months of supplementation of 5 grams per day of creatine monohydrate while following their normal lifestyle practices. At baseline and six months after study initiation, participants will complete laboratory assessments. These assessments will include a standard blood draw for evaluation of total testosterone (T), free T, dihydrotestosterone (DHT), and DHT:T ratios in the blood, as well as global photography and questionnaires to evaluate hair loss. This study will examine the claim that creatine increases DHT concentrations and and DHT:T ratio, as well as provide novel data regarding whether creatine promotes hair loss.

Conditions

Interventions

DIETARY_SUPPLEMENT

Creatine Monohydrate Supplementation

Participants in the creatine monohydrate supplementation arm will consume 5 grams per day of creatine monohydrate.

DIETARY_SUPPLEMENT

Placebo Supplementation

Participants in the placebo supplementation arm will consume 5 grams per day of maltodextrin placebo.

Sponsors & Collaborators

  • Legion Athletics, Inc

    collaborator UNKNOWN

  • Texas Tech University

    lead OTHER

Principal Investigators

  • Grant M Tinsley, PhD · Texas Tech University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04298840 on ClinicalTrials.gov